032566784	032566784	CD	B-NP	O
|	|	NN	I-NP	O
LCSMC	LCSMC	NN	I-NP	O
|	|	NN	I-NP	O
32147963	32147963	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8586657	8586657	CD	B-NP	O
|	|	CC	I-NP	O
9/20/2005	9/20/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
hereditary	hereditary	JJ	I-NP	O
angioedema	angioedema	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/13/2005	10/13/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/6/2005	10/6/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
BRUNSCHEEN	BRUNSCHEEN	NN	I-NP	O
,	,	,	O	O
GARTH	GARTH	NNP	B-NP	O
H.	H.	NNP	I-NP	O
882-12-27-0	882-12-27-0	CD	I-NP	O
Co	Co	NNP	I-NP	O
Room	Room	NNP	I-NP	O
:	:	:	O	O
Jack	Jack	NNP	B-NP	O
,	,	,	O	O
Texas	Texas	NNP	B-NP	O
78463	78463	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
9/15/05	9/15/05	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FLEMISTER	FLEMISTER	NN	B-NP	O
,	,	,	O	O
RUEBEN	RUEBEN	NNP	B-NP	O
RANDELL	RANDELL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	B-protein
ACID	ACID	NN	I-NP	I-protein
81	81	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
VIT	VIT	NNP	I-NP	I-protein
C	C	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ASCORBIC	ASCORBIC	NNP	I-NP	I-protein
ACID	ACID	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
ATENOLOL	ATENOLOL	NN	I-NP	I-protein
75	75	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	B-VP	O
60	60	CD	B-NP	O
DIGOXIN	DIGOXIN	NN	I-NP	O
0.125	0.125	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QOD	QOD	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Sun	Sun	NNP	B-NP	O
,	,	,	O	O
Tues	Tues	NNP	B-NP	O
,	,	,	O	O
Thurs	Thurs	NNP	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
by	by	IN	B-PP	O
LEEMING	LEEMING	NNP	B-NP	O
,	,	,	O	O
ARMANDO	ARMANDO	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SYNTHROID	SYNTHROID	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
39738883	39738883	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
0.1875	0.1875	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QOD	QOD	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
M	M	NNP	B-NP	O
,	,	,	O	O
W	W	NNP	B-NP	O
,	,	,	O	O
F	F	NNP	B-NP	O
,	,	,	O	O
Sat	Sat	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
by	by	IN	B-PP	O
BRUNFIELD	BRUNFIELD	NNP	B-NP	O
,	,	,	O	O
BEAU	BEAU	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
COLACE	COLACE	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
PEPCID	PEPCID	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FAMOTIDINE	FAMOTIDINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
therapeutic	therapeutic	JJ	B-NP	O
interchange	interchange	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
by	by	IN	B-PP	O
HOEPPNER	HOEPPNER	NN	B-NP	O
,	,	,	O	O
ARCHIE	ARCHIE	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
23071938	23071938	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
RASH	RASH	NN	B-NP	B-protein
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
SYNTHROID	SYNTHROID	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
by	by	IN	B-PP	O
FELVER	FELVER	NNP	B-NP	O
,	,	,	O	O
BERNARDO	BERNARDO	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
41263056	41263056	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
by	by	IN	B-PP	O
SAAR	SAAR	NNP	B-NP	B-protein
,	,	,	O	O
HERSCHEL	HERSCHEL	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
SENNA	SENNA	NN	B-NP	B-protein
TABLETS	TABLETS	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
STANOZOLOL	STANOZOLOL	NN	I-NP	O
4	4	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	IN	B-PP	O
AM	AM	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/29	11/29	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
VIT	VIT	NN	I-NP	B-protein
E	E	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
TOCOPHEROL-DL-ALPHA	TOCOPHEROL-DL-ALPHA	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
400	400	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
KEFLEX	KEFLEX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
CEPHALEXIN	CEPHALEXIN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QID	QID	NN	I-NP	I-protein
X	X	SYM	B-VP	I-protein
28	28	CD	B-NP	I-protein
doses	dose	NNS	I-NP	I-protein
Starting	Start	VBG	B-VP	I-protein
Today	Today	NN	B-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
6/11	6/11	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
by	by	IN	B-PP	O
MCWELLS	MCWELLS	NN	B-NP	O
,	,	,	O	O
COURTNEY	COURTNEY	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KEFLEX	KEFLEX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
32504668	32504668	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Penicillins	Penicillins	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
RASH	RASH	NN	B-NP	B-protein
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
has	have	VBZ	B-VP	O
tolerated	tolerate	VBN	I-VP	O
in	in	IN	B-PP	O
past	past	JJ	B-NP	B-DNA
ok	ok	NN	I-NP	I-DNA
RHINOCORT	RHINOCORT	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
BUDESONIDE	BUDESONIDE	NNP	I-NP	I-DNA
NASAL	NASAL	NNP	I-NP	I-DNA
INHALER	INHALER	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
2	2	CD	I-NP	I-DNA
SPRAY	SPRAY	NN	I-NP	I-DNA
NA	NA	NN	I-NP	I-DNA
BID	BID	NN	I-NP	I-DNA
ALLEGRA	ALLEGRA	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
FEXOFENADINE	FEXOFENADINE	NN	I-NP	I-DNA
HCL	HCL	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
60	60	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Morrell	Morrell	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Guadagnolo	Guadagnolo	NNP	I-NP	O
or	or	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Yoes	Yoes	NNP	I-NP	O
1-2	1-2	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
IV	IV	CD	B-NP	O
Contrast	Contrast	NN	I-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
QUINIDINE	QUINIDINE	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
,	,	,	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
,	,	,	O	O
NITROFURANTOIN	NITROFURANTOIN	NN	B-NP	B-protein
,	,	,	O	O
STANAZOL	STANAZOL	NN	B-NP	O
,	,	,	O	O
PROCAINE	PROCAINE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
,	,	,	O	O
Dairy	Dairy	NNP	B-NP	O
Products	Products	NNP	I-NP	O
,	,	,	O	O
WHEAT/GLUTEN	WHEAT/GLUTEN	NNP	B-NP	O
,	,	,	O	O
NITROFURANTOIN	NITROFURANTOIN	NNP	B-NP	O
MACROCRYSTAL	MACROCRYSTAL	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
hereditary	hereditary	JJ	I-NP	O
angioedema	angioedema	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HEREDITARY	HEREDITARY	NNP	I-NP	O
ANGIOEDEMA	ANGIOEDEMA	NNP	I-NP	O
AFIB	AFIB	NNP	I-NP	O
-	-	HYPH	B-NP	O
lodose	lodose	JJ	I-NP	O
Coum/ASA	Coum/ASA	NN	I-NP	O
HYPOTHY	HYPOTHY	NN	I-NP	O
H/O	H/O	NN	I-NP	O
SUBDURAL	SUBDURAL	NN	I-NP	O
ON	ON	NN	I-NP	O
COUM	COUM	NN	I-NP	O
S/P	S/P	NN	I-NP	O
APPY	APPY	NN	I-NP	O
,	,	,	O	O
TAH	TAH	NN	B-NP	B-protein
tracheostomies	tracheostomy	NNS	I-NP	I-protein
x	x	SYM	O	I-protein
3	3	CD	B-NP	I-protein
multiple	multiple	JJ	I-NP	O
intubations	intubation	NNS	I-NP	O
DVT	DVT	NN	I-NP	O
,	,	,	O	O
ivc	ivc	NN	B-NP	O
filter	filter	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
GERD	GERD	NN	I-NP	O
polycythemia	polycythemia	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
83	83	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
URI	URI	NN	B-NP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
,	,	,	O	O
but	but	CC	O	O
then	then	RB	B-ADVP	O
woke	wake	VBD	B-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
abd	abd	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
admits	admit	NNS	I-NP	O
in	in	IN	B-PP	O
past	past	NN	B-NP	O
for	for	IN	B-PP	O
GI	GI	NN	B-NP	O
sx	sx	NN	I-NP	O
2/2	2/2	CD	I-NP	O
hereditary	hereditary	JJ	I-NP	O
angioedema	angioedema	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pain	pain	NN	B-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
admit	admit	NN	B-NP	O
same	same	JJ	B-ADJP	O
as	as	IN	B-PP	O
these	these	DT	B-NP	O
episodes	episode	NNS	I-NP	O
.	.	.	O	O

Was	Be	VBD	B-VP	O
not	not	RB	I-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
stanazolol	stanazolol	NN	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
had	have	VBD	B-VP	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
N/V	N/V	NN	B-NP	O
,	,	,	O	O
sweats	sweat	NNS	B-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
POs	PO	NNS	B-NP	B-protein
.	.	.	O	O

Admitted	Admit	VBN	B-VP	O
for	for	IN	B-PP	O
FFP	FFP	NN	B-NP	B-protein
rx	rx	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
usually	usually	RB	B-ADVP	O
resolves	resolve	VBZ	B-VP	O
her	her	PRP$	B-NP	O
sx	sx	NN	I-NP	O
.	.	.	O	O

Baseline	Baseline	NNP	B-NP	O
PE	PE	NNP	I-NP	O
:	:	:	O	O
98.1	98.1	CD	B-NP	O
8594/80	8594/80	CD	I-NP	O
20	20	CD	I-NP	O
94	94	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Very	Very	NNP	I-NP	O
distended	distend	VBD	B-VP	O
,	,	,	O	O
tender	tender	NN	B-NP	O
abdomen	abdomen	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBN	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
Impression	Impression	NN	B-NP	O
:	:	:	O	O
Hereditary	Hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
flare	flare	NN	I-NP	O
with	with	IN	B-PP	O
GI	GI	NN	B-NP	O
manifestations	manifestation	NNS	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
FFP	FFP	NN	I-NP	O
with	with	IN	B-PP	O
premedication	premedication	NN	B-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Benadryl	Benadryl	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
night	night	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
given	give	VBN	I-VP	O
Stanazolol	Stanazolol	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
q4h	q4h	NN	I-NP	O
overnight	overnight	RB	B-ADVP	O
,	,	,	O	O
wh	wh	NN	B-NP	O
ich	ich	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	I-VP	O
bid	bid	VB	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
rhinocort	rhinocort	NN	B-NP	O
and	and	CC	I-NP	O
allegra	allegra	NN	I-NP	O
PAIN	PAIN	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
Dilaudid	Dilaudid	NN	B-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
c	c	NN	B-NP	O
ontinued	ontinue	VBN	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
meds	med	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
ENDO	ENDO	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
synthroid	synthroid	NN	B-NP	O
for	for	IN	B-PP	O
hypothyroid	hypothyroid	JJ	B-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Zantac	Zantac	NN	B-NP	O
and	and	CC	I-NP	O
Stanazolol	Stanazolol	NN	I-NP	O
.	.	.	O	O

PPX	PPX	NN	B-NP	B-protein
:	:	:	O	O
Lovenox	Lovenox	NN	B-NP	O
FULL	FULL	NN	I-NP	O
CODE	CODE	NN	I-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
instructions	instruction	NNS	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
allergy	allergy	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
right	right	RB	B-ADVP	O
away	away	RB	I-ADVP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
concerning	concern	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

Please	Please	NNP	B-NP	O
call	call	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Zaspel	Zaspel	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Muskopf	Muskopf	NNP	I-NP	O
's	's	POS	B-NP	O
offices	office	NNS	I-NP	O
tomorrow	tomorrow	NN	B-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
follow	follow	JJ	B-NP	O
u	u	NN	I-NP	O
p	p	NN	I-NP	O
appointments	appointment	NNS	I-NP	O
for	for	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
WINGENTER	WINGENTER	NNP	B-NP	O
,	,	,	O	O
DARIO	DARIO	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IS559	IS559	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/15/05	9/15/05	CD	I-NP	O
@	@	SYM	B-NP	O
09	09	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

